C16 unsaturated FP-selective prostaglandins analogs

US6586463B2 · kind B2 · utility

Assignee

• The Procter & Gamble Company · US

Inventors

• Mitchell A. deLong · Chapel Hill, US
• David Lindsey Soper · Mason, US
• John August Wos · Cincinnati, US
• Biswanath De · Mason, US

Key dates

• Filing date: Sep 4, 2001
• Grant date: Jul 1, 2003
• Expiry date: Sep 4, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C405/0016
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds having the general structure: which are useful for the treatment of a variety of diseases and conditions, such as bone disorders.